.jpg "Antoinette Gawin photo")
President & Chief Executive Officer
Terumo Blood and Cell Technologies
Antoinette Gawin is the president and chief executive officer of Terumo Blood and Cell Technologies, a $1 billion mission-driven medical technology company that is focused on unlocking the potential of blood and cell-based therapies. The innovative medical technology company strives to advance healthcare, broaden treatment options and improve patient outcomes through its technologies within the sectors of blood banking, transfusion medicine and regenerative medicine.
Gawin focuses on how Terumo Blood and Cell Technologies will continue to evolve with healthcare’s rapid changes to meet more patients' needs globally. She believes medical device manufacturers must change and go beyond equipment to think about services, data management and new geographies where people do not yet have access to the technologies that can advance their health and lives. She is ensuring that Terumo Blood and Cell Technologies continues to focus on service and helping our customers solve problems—enabling them to better serve patients.
Wednesday, September 29, 2021
5:15 PM – 6:10 PM ET